Because patients with chronic kidney disease (CKD) have an increased risk of death from cardiovascular disease, recognizing the pathologic processes of cardiomyopathy and complications that can result in uremic cardiomyopathy is key for nephrology nurses. This session addresses the epidemiology, pathophysiology, diagnosis, and treatment recommendations (including types of dialysis) for cardiomyopathy in patients with CKD. The relationship of uremic cardiomyopathy to mineral and bone disorders seen in CKD is also discussed.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 5/5/2023.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.

Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.

ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
Upon completion of this activity, the learner will be able to care for patients with CKD who are developing uremic cardiomyopathy with early recognition of this complication.